Novel Hydrogel: Targeted Delivery of Drugs for Rheumatoid Arthritis Patients

News   Oct 12, 2017 | Original story from the Institute for Basic Research

 
Novel Hydrogel: Targeted Delivery of Drugs for Rheumatoid Arthritis Patients

IBS scientists developed a hydrogel made of polymeric acrylamide (blue spaghetti) linked with crosslinkers (black), which can accommodate drug molecules (purple stars) within its mesh (grey). In the presence of nitric oxide (red), the linker is cleaved and the drug molecules can be released. At the same time, the gel absorbs fluid from the surroundings and swells in size. Image credit: Park J. et al, Advanced Materials (2017)

 
 
 

RELATED ARTICLES

Protein Target Identified That Could Prevent Strokes

News

Scientists have identified a protein, called GPR68, that senses blood flow and tells small blood vessels called arterioles when to dilate. The researchers believe medications that activate GPR68 could one day be useful to treat medical conditions, including ischemic stroke.

READ MORE

How Environmental Pollutants and Genetics Work Together in Rheumatoid Arthritis

News

It is well known that individuals with a particular version of human leukocyte antigen have an increased risk for rheumatoid arthritis, but there has been growing interest in the role of environmental pollutants. In a new mouse study, researchers probed the relationship between the two.

READ MORE

Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug Discovery

News

Scientists solve the crystal structure of Neuropeptide Y Y1 Receptor, offering new opportunities for anti-obesity drug discovery.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE